150
Participants
Start Date
November 5, 2021
Primary Completion Date
December 31, 2025
Study Completion Date
December 31, 2025
Depo-Medrol 40Mg/Ml Suspension for Injection
40mg Depo-Medrol mixed with hemostatic matrix
Placebo
1 mL of sterile normal saline mixed with hemostatic matrix
RECRUITING
Hospital for Special Surgery, New York
Hospital for Special Surgery, New York
OTHER